期刊文献+

Tong xie yao fang relieves irritable bowel syndrome in rats via mechanisms involving regulation of 5-hydroxytryptamine and substance P 被引量:29

Tong xie yao fang relieves irritable bowel syndrome in rats via mechanisms involving regulation of 5-hydroxytryptamine and substance P
下载PDF
导出
摘要 AIM: To investigate whether the Chinese medicine Tong Xie Yao Fang(TXYF) improves dysfunction in an irritable bowel syndrome(IBS) rat model. METHODS: Thirty baby rats for IBS modeling were separated from mother rats(1 h per day) from days 8 to 21, and the rectum was expanded by angioplasty from days 8 to 12. Ten normal rats were used as normal controls. We examined the effects of TXYF on defection frequency, colonic transit function and smooth muscle contraction, and the expression of 5-hydroxytryptamine(5-HT) and substance P(SP) in colonic and hypothalamus tissues by Western blot and RT-PCT techniques in both normal rats and IBS model rats with characterized visceral hypersensitivity.in normal rats and 4.5 ± 1.58 in IBS model rats(P < 0.001). However, the defecation frequency was significantly decreased(3.0 ± 1.25 vs 4.5 ± 1.58, P < 0.05), while the time(in seconds) of colon transit function was significantly increased(256.88 ± 20.32 vs 93.36 ± 17.28, P < 0.001) in IBS + TXYF group rats than in IBS group rats. Increased colonic smooth muscle tension and contract frequency in IBS model rats were significantly decreased by administration of TXYF. Exogenous agonist stimulants increased spontaneous activity and elicited contractions of colon smooth muscle in IBS model rats, and all of these actions were significantly reduced by TXYF involving 5-HT and SP down-regulation. CONCLUSION: TXYF can modulate the activity of the enteric nervous system and alter 5-HT and SP activities, which may contribute to the symptoms of IBS. AIM: To investigate whether the Chinese medicine Tong Xie Yao Fang(TXYF) improves dysfunction in an irritable bowel syndrome(IBS) rat model. METHODS: Thirty baby rats for IBS modeling were separated from mother rats(1 h per day) from days 8 to 21, and the rectum was expanded by angioplasty from days 8 to 12. Ten normal rats were used as normal controls. We examined the effects of TXYF on defection frequency, colonic transit function and smooth muscle contraction, and the expression of 5-hydroxytryptamine(5-HT) and substance P(SP) in colonic and hypothalamus tissues by Western blot and RT-PCT techniques in both normal rats and IBS model rats with characterized visceral hypersensitivity.in normal rats and 4.5 ± 1.58 in IBS model rats(P < 0.001). However, the defecation frequency was significantly decreased(3.0 ± 1.25 vs 4.5 ± 1.58, P < 0.05), while the time(in seconds) of colon transit function was significantly increased(256.88 ± 20.32 vs 93.36 ± 17.28, P < 0.001) in IBS + TXYF group rats than in IBS group rats. Increased colonic smooth muscle tension and contract frequency in IBS model rats were significantly decreased by administration of TXYF. Exogenous agonist stimulants increased spontaneous activity and elicited contractions of colon smooth muscle in IBS model rats, and all of these actions were significantly reduced by TXYF involving 5-HT and SP down-regulation. CONCLUSION: TXYF can modulate the activity of the enteric nervous system and alter 5-HT and SP activities, which may contribute to the symptoms of IBS.
出处 《World Journal of Gastroenterology》 SCIE CAS 2015年第15期4536-4546,共11页 世界胃肠病学杂志(英文版)
基金 Supported by National Education Department"ChunHui Plan"Research Projects,No.Z2010021 China Postdoctoral Science Foundation Project,No.2013M531079 Heilongjiang Postdoctoral Funding Project,No.LBH-Z12246 Heilongjiang Education Department Scientific Research Project,No.12521502 excellent Innovative Talents Support Program Funding of Heilongjiang University of Chinese Medicine(Outstanding Young Academic Leaders),No.051217
关键词 Tong Xie YAO Fang IRRITABLE BOWEL SYNDROME 5-HYDROXYTRYPTAMINE Substance P TRADITIONAL Chinesemedicine Tong Xie Yao Fang Irritable bowel syndrome 5-hydroxytryptamine Substance P Traditional Chinese medicine
  • 相关文献

参考文献19

  • 1Hou WR, Hou YL, Wu GF, Song Y, Su XL, Sun B, Li J. cDNA,genomic sequence cloning and overexpression of ribosomal proteingene L9 (rpL9) of the giant panda (Ailuropoda melanoleuca).Genet Mol Res 2011; 10: 1576-1588 [PMID: 21863553 DOI:10.4238/vol10-3gmr1159].
  • 2Heitkemper M, Jarrett M, Jun SE. Update on irritable bowelsyndrome program of research. J Korean Acad Nurs 2013; 43:579-586 [PMID: 24351989 DOI: 10.4040/jkan.2013.43.5.579].
  • 3Gershon MD. Nerves, reflexes, and the enteric nervous system:pathogenesis of the irritable bowel syndrome. J Clin Gastroenterol2005; 39: S184-S193 [PMID: 15798484 DOI: 10.1097/01.mcg.0000156403.37240.30].
  • 4Mulak A, Bonaz B. Irritable bowel syndrome: a model of thebrain-gut interactions. Med Sci Monit 2004; 10: RA55-RA62[PMID: 15260348].
  • 5Stasi C, Bellini M, Bassotti G, Blandizzi C, Milani S. Serotoninreceptors and their role in the pathophysiology and therapy ofirritable bowel syndrome. Tech Coloproctol 2014; 18: 613-621[PMID: 24425100 DOI: 10.1007/s10151-013-1106-8].
  • 6Whitehead WE, Palsson OS, Gangarosa L, Turner M, TuckerJ. Lubiprostone does not influence visceral pain thresholds inpatients with irritable bowel syndrome. NeurogastroenterolMotil 2011; 23: 944-e400 [PMID: 21914041 DOI: 10.1111/j.1365-2982.2011.01776.x].
  • 7Wang WF, Yang YS, Peng LH, Sun G. Alternation of substanceP-containing neural pathways in a rat model of irritable bowelsyndrome with rectal distension. Chin J Dig Dis 2006; 7: 211-218[PMID: 17054583 DOI: 10.1111/j.1443-9573.2006.00273.x].
  • 8Gui XY, Pan GZ, Ke MY. Effect of gastrointestinal peptides incolonic motility disorders induced bystress. Zhongguo XiaohuaZazhi 1997; 2: 94-96.
  • 9Zhang Y, Bo P, Li X. Increased incidence of bowel andpsychological symptoms in Chinese female D-IBS patients withpremenstrual syndrome. Gastroenterol Nurs 2014; 37: 351-359[PMID: 25271828 DOI: 10.1097/SGA.0000000000000067].
  • 10Bian Z, Wu T, Liu L, Miao J, Wong H, Song L, Sung JJ.Effectiveness of the Chinese herbal formula TongXieYaoFangfor irritable bowel syndrome: a systematic review. J AlternComplement Med 2006; 12: 401-407 [PMID: 16722791 DOI:10.1089/acm.2006.12.401].

同被引文献355

引证文献29

二级引证文献219

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部